{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:20:00Z","timestamp":1785831600023,"version":"3.56.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["K08HS025782"],"award-info":[{"award-number":["K08HS025782"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR001077"],"award-info":[{"award-number":["KL2TR001077"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sherrilyn and Ken Fisher Center"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Patients increasingly receive home-based outpatient parenteral antimicrobial therapy (OPAT). Understanding which patients might be at higher risk of complications is critical in effectively triaging resources upon and after hospital discharge.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A prospective cohort of patients discharged from 1 of 2 academic medical centers in Baltimore, Maryland, between March 2015 and December 2018 were consented and randomly divided into derivation and validation cohorts for development of a risk score for adverse OPAT outcomes. Data from the derivation cohort with the primary outcome of a serious adverse outcome (infection relapse, serious adverse drug event, serious catheter complication, readmission, or death) were analyzed to derive the risk score equation using logistic regression, which was then validated in the validation cohort for performance of predicting a serious adverse outcome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 664 patients in the total cohort, half (332) experienced a serious adverse outcome. The model predicting having a serious adverse outcome included type of catheter, time on OPAT, using a catheter for chemotherapy, using a catheter for home parenteral nutrition, being treated for septic arthritis, being on vancomycin, being treated for Enterococcus, being treated for a fungal infection, and being treated empirically. A score\u2005\u22652 on the serious adverse outcome score had a 94.0% and 90.9% sensitivity for having a serious adverse outcome in the derivation and validation cohorts, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>A risk score can be implemented to detect who may be at high risk of serious adverse outcomes, but all patients on OPAT may require monitoring to prevent or detect adverse events.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofaa178","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T18:21:23Z","timestamp":1589998883000},"source":"Crossref","is-referenced-by-count":30,"title":["Which Patients Discharged to Home-Based Outpatient Parenteral Antimicrobial Therapy Are at High Risk of Adverse Outcomes?"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9660-4367","authenticated-orcid":false,"given":"Sara C","family":"Keller","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Johns Hopkins University School of Medicine, Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6513-9730","authenticated-orcid":false,"given":"Nae-Yuh","family":"Wang","sequence":"first","affiliation":[{"name":"Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University School of Medicine, Institute for Clinical & Translational Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Salinas","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Williams","sequence":"first","affiliation":[{"name":"Johns Hopkins Home Care Group, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7587-3493","authenticated-orcid":false,"given":"Jennifer","family":"Townsend","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9458-4331","authenticated-orcid":false,"given":"Sara E","family":"Cosgrove","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Johns Hopkins University School of Medicine, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,5,20]]},"reference":[{"key":"2020060403500741600_CIT0001","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciy745","article-title":"2018 Infectious Diseases Society of America clinical practice guideline for the management of outpatient parenteral antimicrobial therapy","volume":"68","author":"Norris","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020060403500741600_CIT0002","doi-asserted-by":"crossref","first-page":"e024564","DOI":"10.1136\/bmjopen-2018-024564","article-title":"Quality of outpatient parenteral antimicrobial therapy (OPAT) care from the patient\u2019s perspective: a qualitative study","volume":"8","author":"Berrevoets","year":"2018","journal-title":"BMJ Open"},{"key":"2020060403500741600_CIT0003","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/cid\/cix733","article-title":"Rates of and risk factors for adverse drug events in outpatient parenteral antimicrobial therapy","volume":"66","author":"Keller","year":"2018","journal-title":"Clinical Infect Dis"},{"key":"2020060403500741600_CIT0004","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/cid\/ciz073","article-title":"Early infectious disease outpatient follow-up of outpatient parenteral antimicrobial therapy patients reduces 30-day readmission","volume":"69","author":"Saini","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020060403500741600_CIT0005","doi-asserted-by":"crossref","first-page":"XXX","DOI":"10.1093\/ofid\/ofz363","article-title":"Perspectives of United States-based infectious diseases physicians on outpatient parenteral antimicrobial therapy practice","volume":"6","author":"Hamad","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2020060403500741600_CIT0006","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/phar.2099","article-title":"Antimicrobial agents and catheter complications in outpatient parenteral antimicrobial therapy","volume":"38","author":"Keller","year":"2018","journal-title":"Pharmacotherapy"},{"key":"2020060403500741600_CIT0007","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1017\/ice.2016.223","article-title":"Environmental exposures and the risk of central venous catheter complications and readmissions in home infusion therapy patients","volume":"38","author":"Keller","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2020060403500741600_CIT0008","doi-asserted-by":"crossref","first-page":"XXX\u2013XX","DOI":"10.1093\/ofid\/ofy143","article-title":"Health-related quality of life in outpatient parenteral antimicrobial therapy","volume":"5","author":"Keller","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2020060403500741600_CIT0009","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1017\/ice.2016.223","article-title":"Environmental exposures and the risk of central venous catheter complications and readmissions in home infusion therapy patients","volume":"38","author":"Keller","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2020060403500741600_CIT0010","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1093\/cid\/civ750","article-title":"What medicare is missing","volume":"61","author":"Keller","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2020060403500741600_CIT0011","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0038-1634956","article-title":"Risk adjustment in outcome assessment: the Charlson comorbidity index","volume":"32","author":"D\u2019Hoore","year":"1993","journal-title":"Methods Inf Med"},{"key":"2020060403500741600_CIT0012","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/1475-6773.00165","article-title":"Improved comorbidity adjustment for predicting mortality in Medicare populations","volume":"38","author":"Schneeweiss","year":"2003","journal-title":"Health Serv Res"},{"key":"2020060403500741600_CIT0013","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jclinepi.2016.03.031","article-title":"Regression coefficient-based scoring system should be used to assign weights to the risk index","volume":"79","author":"Mehta","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2020060403500741600_CIT0014","doi-asserted-by":"crossref","first-page":"e1001922","DOI":"10.1371\/journal.pmed.1001922","article-title":"Self-Administered outpatient antimicrobial infusion by uninsured patients discharged from a safety-net hospital: a propensity-score-balanced retrospective cohort study","volume":"12","author":"Bhavan","year":"2015","journal-title":"PLoS Med"},{"key":"2020060403500741600_CIT0015","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1017\/ice.2018.107","article-title":"A retrospective analysis of adverse events among patients receiving daptomycin versus vancomycin during outpatient parenteral antimicrobial therapy","volume":"39","author":"Schrank","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2020060403500741600_CIT0016","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/cid\/ciz150","article-title":"Close patient follow-up among patients receiving outpatient parenteral antimicrobial therapy","volume":"70","author":"Palms","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2020060403500741600_CIT0017","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/cid\/ciy674","article-title":"Infectious diseases specialty intervention is associated with better outcomes among privately insured individuals receiving outpatient parenteral antimicrobial therapy","volume":"68","author":"Shah","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020060403500741600_CIT0018","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1128\/AAC.03011-15","article-title":"Epidemiology of acute kidney injury among patients receiving concomitant vancomycin and piperacillin-tazobactam: opportunities for antimicrobial stewardship","volume":"60","author":"Karino","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2020060403500741600_CIT0019","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1062860619853345","article-title":"It\u2019s complicated: patient and informal caregiver performance of outpatient parenteral antimicrobial therapy-related tasks","volume":"35","author":"Keller","year":"2020","journal-title":"Am J Med Qual"},{"key":"2020060403500741600_CIT0020","first-page":"763","article-title":"Roles and role ambiguity in patient- and caregiver-performed outpatient parenteral antimicrobial therapy","volume":"45","author":"Keller","year":"2019","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"2020060403500741600_CIT0021","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/8755122513500922","article-title":"The impact of an infectious diseases transition service on the care of outpatients on parenteral antimicrobial therapy","volume":"29","author":"Keller","year":"2013","journal-title":"J Pharm Technol"},{"key":"2020060403500741600_CIT0022","first-page":"XXX","article-title":"Patient experiences with outpatient parenteral antibiotic therapy: results of a patient survey comparing skilled nursing facilities and home infusion","volume":"6","author":"Mansour","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2020060403500741600_CIT0023","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1532-5415.2007.01133.x","article-title":"Home intravenous antimicrobial infusion therapy: a viable option in older adults","volume":"55","author":"Cox","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"2020060403500741600_CIT0024","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1007\/s10096-012-1604-z","article-title":"Self-administration of outpatient parenteral antibiotic therapy and risk of catheter-related adverse events: a retrospective cohort study","volume":"31","author":"Barr","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020060403500741600_CIT0025","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1742-1241.2008.01747.x","article-title":"Safety and efficacy of home intravenous antimicrobial infusion therapy in older patients: a comparative study with younger patients","volume":"62","author":"P\u00e9rez-L\u00f3pez","year":"2008","journal-title":"Int J Clin Pract"},{"key":"2020060403500741600_CIT0026","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3121\/cmr.2013.1113","article-title":"Patient characteristics associated with medication adherence","volume":"11","author":"Rolnick","year":"2013","journal-title":"Clin Med Res"},{"key":"2020060403500741600_CIT0027","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1086\/671737","article-title":"The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis","volume":"34","author":"Chopra","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2020060403500741600_CIT0028","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2020060403500741600_CIT0029","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ1194","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020060403500741600_CIT0030","first-page":"e394","article-title":"Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America","volume":"111","author":"Baddour","year":"2005","journal-title":"Circulation"},{"key":"2020060403500741600_CIT0031","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/jac\/dkt512","article-title":"Adverse events, healthcare interventions and healthcare utilization during home infusion therapy with daptomycin and vancomycin: a propensity score-matched cohort study","volume":"69","author":"Shrestha","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2020060403500741600_CIT0032","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/jac\/dkn080","article-title":"Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy","volume":"62","author":"Ingram","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"2020060403500741600_CIT0033","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jac\/dkt402","article-title":"Risk factors for nephrotoxicity in patients receiving outpatient continuous infusions of vancomycin in an Australian tertiary hospital","volume":"69","author":"Norton","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2020060403500741600_CIT0034","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"77","author":"Ryback","year":"2020","journal-title":"Am J Health-System Pharmacy"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaa178\/33241547\/ofaa178.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/7\/6\/ofaa178\/33343540\/ofaa178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/7\/6\/ofaa178\/33343540\/ofaa178.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T07:50:47Z","timestamp":1591257047000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaa178\/5841133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,20]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaa178","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6]]},"published":{"date-parts":[[2020,5,20]]},"article-number":"ofaa178"}}